Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: T3
Or Leckrone is in absolute control and we negotiated nothing with our Leckrone settlement. I would hope management would give long term shareholders an indication that great things will happen if we get a favorable T3 outcome. It is the least they could do. Otherwise make it clear we are going no where and SPs of the past will not happen again. Please let us know the endgame. GLTAL
Share
New Message
Please login to post a reply